Epoetin theta

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin theta
Drug Alias Name依泊汀θepoetina zeta促红素θepoetinum thetaEporatio +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemiaKidney Failure, Chronic
Global Approved IndicationsAnemiaKidney Failure, Chronic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2009/10/23
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTeva Gmbh
Inactive CompaniesN/A
Active IndicationsAnemiaKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A